2024 年 1 月 30 日
2024 年 1 月 30 日

Overview of Key Biotech and Pharmaceutical Issues in Taiwan for 2023

Alert January 2024
Biotech and Pharmaceutical Law Team of Lee, Tsai & Partners
Do you like it?
Read more
2023 年 12 月 21 日
2023 年 12 月 21 日

The Prohibition on Physicians Posting Medical Advertisements was declared Unconstitutional by the Taiwan Constitutional Court

Alert December 2023
Oli Wong and Sean Tang
Do you like it?
Read more
2023 年 8 月 30 日
2023 年 8 月 30 日

Streamlined Examination Process for Pharmaceutical Patent Term Extension (Taiwan)

Alert August 2023
Teresa Huang and Albert Yen
Do you like it?
Read more
2023 年 1 月 18 日
2023 年 1 月 18 日

Draft Amendments to the Rules of Medical Diagnosis and Treatment by Telecommunications Pre-announced by the MOHW of Taiwan

Alert January 2023
Teresa Huang and Tina Lee
Do you like it?
Read more
2022 年 11 月 9 日
2022 年 11 月 9 日

Draft “Restrictions on Investment by Medical Juridical Persons Under Article 35, Paragraph 1 of the Medical Care Act” Pre-announced by the MOHW

Alert November 2022
Teresa Huang and Sean Tang
Do you like it?
Read more
2022 年 9 月 29 日
2022 年 9 月 29 日

Sub-laws of the Act for the Development of Biotech and Pharmaceutical Industry Enacted and Promulgated by the MOEA and the MOF of Taiwan

Alert September 2022
Biotech and Pharmaceutical Law Team of Lee, Tsai & Partners
Do you like it?
Read more
2022 年 9 月 2 日
2022 年 9 月 2 日

Reflection on the Benefit Sharing Mechanism for Providers of Specimens or Biological Data in Regenerative Therapy Research (Taiwan)

Feature Article September 2022
Dr. Chung-Teh Lee, Teresa Huang, Hannah Kuo, and Sally Yang
Do you like it?
Read more
2022 年 8 月 10 日
2022 年 8 月 10 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

Feature Article August 2022
Teresa Huang and Sally Yang
Do you like it?
Read more
2022 年 8 月 4 日
2022 年 8 月 4 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies’ Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

Feature Article August 2022
Teresa Huang and Hannah Kuo
Do you like it?
Read more
2022 年 7 月 26 日
2022 年 7 月 26 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (IV) –The MOEA of Taiwan Announced the Regulatory Highlights of the Drafts Concerning the Tax Credits for the Income from Investment in Biological or Pharmaceutical Companies by Profit-seeking Enterprises or Individuals

Feature Article July 2022
Teresa Huang and Tina Lee
Do you like it?
Read more
2022 年 7 月 19 日
2022 年 7 月 19 日

Regulations for the Implementation of the Drug Administration Law (Draft Revision for Comments) in Mainland China Focused Interpretation

Insight July 2022
Karl Zhang and Teresa Huang
Do you like it?
Read more
2022 年 7 月 19 日
2022 年 7 月 19 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (III) – The Draft Regulations Governing the Applicability of Investment Tax Credits to Biotech and Pharmaceutical Companies’ Investments in Machinery, Equipment or Systems, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

Feature Article July 2022
Teresa Huang and Oli Wong
Do you like it?
Read more
2022 年 7 月 13 日
2022 年 7 月 13 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (II) – the Draft Regulations Governing the Applicability of Investment Tax Credits to Biotech and Pharmaceutical Companies’ Research and Development Expenditures, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

Feature Article July 2022
Teresa Huang and Oli Wong
Do you like it?
Read more
2022 年 6 月 30 日
2022 年 6 月 30 日

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (I) ─ Implementation Highlights of the Act for the Development of Biotech and Pharmaceutical Industry and the Draft Regulations Governing the Approval of Biotech and Pharmaceutical Companies, Which Is the Sub-law Pre-announced by the MOEA of Taiwan

Feature Article June 2022
Teresa Huang and Oli Wong
Do you like it?
Read more
2022 年 3 月 25 日
2022 年 3 月 25 日

Summary of the Draft Amendments to Taiwan MOHW’s Scientific and Technological Research and Development Results Ownership and Utilization Regulations

Alert March 2022
Teresa Huang and Albert Yen
Do you like it?
Read more
2021 年 9 月 22 日
2021 年 9 月 22 日

Guidelines for the new Medical Devices Act (Taiwan)

Teresa Huang and Oli Wong[1] Medical devices are governed previously under the Pharmaceutical Affairs Act. On December 13, 2019, the Legislative Yuan adopted the “Medical Devices Act” (the “Act”) through the third-readings procedure, separating the governance of such medical devices […]
Do you like it?
Read more
2021 年 9 月 1 日
2021 年 9 月 1 日

Introduction to the Draft Amendment to the Regulations for Medicine Safety Monitoring (Taiwan)

Jane Tsai and Eddie Shih I. Summary of the Draft Amendments Taiwan’s Central Competent Health Authority Ministry of Health and Welfare (hereinafter, the “MOHW”) pre-announced on August 3rd, 2021 a draft amendment to the Regulations for Medicine Safety Monitoring (hereinafter, […]
Do you like it?
Read more